Britta Brix

Britta Brix, PhD, currently serves as the Head of Medical Science Liaison Management for Amyloidosis and Head of Medical Project Management for Heart Failure at AstraZeneca since March 2023. Prior to this role, Britta Brix held multiple positions at EUROIMMUN from January 2013 to July 2022, including Head of Global Product Management for Neurodegeneration and Head of the Neurodegenerative Diseases Department. Britta Brix began their career at Universität zu Lübeck, where involvement as a PhD student took place from 2008 to 2011, after earning a Master of Science (M.Sc.) degree in Molecular Life Sciences from the same institution between 2003 and 2008.